mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |